Thomas Kent

(Mr. Thomas Kent Ph.D.)

Currently holds a position at Tekla Life Sciences Investors

Positions
Position Company Period
Independent Trustee Tekla Life Sciences Investors Jan. 1, 2017 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2018-01-29 2018-01-25
B Purchase
1,100 +inf%
24.19
26,605 USD 		1,100 +inf% 24.19 26,605 USD
2018-01-29 2018-01-25
B Purchase
1,400 +inf%
18.50
25,903 USD 		1,400 +inf% 18.50 25,903 USD
2018-01-29 2018-01-25
B Purchase
1,300 +inf%
21.04
27,348 USD 		1,300 +inf% 21.04 27,348 USD
2018-01-29 2018-01-25
B Purchase
1,800 +inf%
14.52
26,128 USD 		1,800 +inf% 14.52 26,128 USD